New to Insight Pharma Reports is Macrocycles:
Discovery, Development & Technologies
This report covers background
material including a more in depth analysis of what macrocycles are and the
pharmacokinetic properties (absorption, distribution, metabolism, and
excretion) they exhibit. Challenges, benefits, and additional properties that
are considered with their development as drugs are covered as well.
Additionally, this report details specifics in technologies and current
research in development.
- Expert Interviews with Bicycle Therapeutics,
Encycle Therapeutics, Ensemble Therapeutics, Lanthio Pharma, Oncodesign,
Pepscan, PeptiDream, RA Pharmaceuticals, Tranzyme, Pharmaceuticals and
- Also exclusive to this report is a survey
conducted by Insight Pharma Reports. This survey includes over 90 participants
from the various organizations including academic and government institutions,
pharmaceutical companies, and biotechnology companies.
- In depth analysis of what macrocycles are and
the pharmacokinetic properties they exhibit
- Reviews specifics in technologies and current
research in development
- Detailed descriptions of company overviews,
technology platforms, benefits, challenges, competitive advantages,
partnerships and future aspirations